Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_2
4
100%

Phase Distribution

0

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
4(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 24 (100.0%)

Trials by Status

completed250%
not_yet_recruiting125%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingphase_2

TU-100 for Accelerating GI Recovery After Major Abdominopelvic Surgery (RC & CAWR)

NCT07765589
completedphase_2

Safety and Efficacy of TU-100 as an Adjunct to an Enhanced Recovery After Surgery in Subjects Undergoing Bowel Resection

NCT04742907
completedphase_2

A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel Syndrome

NCT02074579
terminatedphase_2

A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease

NCT01388933

Clinical Trials (4)

Showing 4 of 4 trials
NCT07765589Phase 2

TU-100 for Accelerating GI Recovery After Major Abdominopelvic Surgery (RC & CAWR)

Not Yet Recruiting
NCT04742907Phase 2

Safety and Efficacy of TU-100 as an Adjunct to an Enhanced Recovery After Surgery in Subjects Undergoing Bowel Resection

Completed
NCT02074579Phase 2

A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel Syndrome

Completed
NCT01388933Phase 2

A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4